Ivan Ivanov, PhD

Medical Writer at Sciencefiles
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Tbilisi, Georgia, GE
Languages
  • English Limited working proficiency
  • Russian Native or bilingual proficiency

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

5.0

/5.0
/ Based on 2 ratings
  • (2)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

LinkedIn User

Ivan was among the graduates of our Colorcon Coating School in February 2015. Interaction with the speaker and other participants showed his deep interest to the content of our educational event. The knowledge that he demonstrated that time, represented him as a beginning and promising specialist in the field of pharmaceutical technology.

Stanislav Fradkin (Станислав Фрадкин)

I enjoyed working with Ivan, he was always very professional, project oriented and results driven. He had a deep understanding of the tasks he was responsible for and was always able to add value to his projects. I would have no hesitation in recommending Ivan to other employers.

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Russian Federation
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Medical Writer
      • Nov 2022 - Present

      At Sciencefiles LLC, I work as a medical writer, and the company was the market leader in these fields in the Eurasian Economic Union. During my time there, I formed a section on preclinical and clinical overviews of a common technical document (CTD) format for the registration dossier. At Sciencefiles LLC, I work as a medical writer, and the company was the market leader in these fields in the Eurasian Economic Union. During my time there, I formed a section on preclinical and clinical overviews of a common technical document (CTD) format for the registration dossier.

    • Senior Process Engineer
      • Jan 2022 - Jan 2023

      At "Scientific and Production Association AXON" LLC, a young company established as part of the fulfillment of obligations under a state-supported grant, I worked on the R&D of a tissue adhesive in the form of a spray. This work was also supported by a government grant, and I optimized the adhesive production in the laboratory and selected packaging for the composition to improve the spray pattern. We produced an experimental batch of fabric adhesive and participated in the patenting of the composition. The product has been well-received by specialists at the country's leading surgical center, who have noted a significant 30% reduction in trauma. Show less

    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Project Manager
      • Aug 2022 - Oct 2022

      AVVA RUS JSC is a pharmaceutical company that is part of a pharmaceutical holding together with the Swiss company AVVA Pharmaceuticals AG. I overseed the new product development of cephalosporinus and cardiac drugs from start to finish. Also I identifyed technical requirements and opportunities, ensures elaboration of project development plan, overseed other company departments and create reports for represent results in front of shareholder. The high prospects of these projects were revealed, the shareholder supported the launch of the product. Show less

    • Process Engineer
      • Nov 2014 - Aug 2022

      JSC "Institute of Pharmaceutical Technologies" is a small enterprise that specializes in the development of dosage forms on a turnkey basis. The company actively invests in advanced technologies for drug production, such as microreactors and innovative packaging solutions (DosePan). As a result of their dedication to innovation, the company has received multiple grants. During my time with the company, I have achieved several notable accomplishments. - Firstly, I worked as part of a team responsible for implementing state-supported grants. Through this effort, we developed schemes for obtaining 3 active substances and subsequently developed 3 dosage forms based on them. The resulting substances and dosage forms were standardized and passed preclinical studies for efficacy and safety. - Secondly, I was responsible for developing technical documentation for one of the largest pharmaceutical manufacturers in the world, with an annual income exceeding 3 billion dollars. Specifically, I created documentation for 3 drugs used in cardiology and oncology. - Thirdly, I acted as a process engineer for R&D blister machine by Rohrer AG (Möhlin, Switzerland) for liquid dosage forms, such as vaccines and eye drops. I also conducted pilot studies to optimize packaging for the Luer-Lock system using 3D printing technology. - Lastly, I organized and launched small-scale production of 2 stock keeping units of disinfectants. Show less

    • Russian Federation
    • Education Administration Programs
    • 1 - 100 Employee
    • Assistant Lecturer
      • Oct 2021 - Jul 2022

      - A patented synthesis of the oligomeric form of a guanidine derivative has been developed in a microreactor, followed by standardization of the compound. Using the synthesized substance, eye drops have been created to treat bacterial and viral conjunctivitis. Preclinical trials have confirmed the effectiveness of the developed drug composition. Flexible materials, including aluminum as the main layer, were used for innovative packaging technology of the drug. As a result of this work, a Ph.D. thesis in pharmaceutical sciences was successfully defended;- Conducting laboratory work with students on the chemical technology of biologically active substances;- Served as secretary of the attestation commission on the defense of master's theses in the areas of training "Pharmaceutical Engineering" and "Industrial Pharmacy". Show less

    • Engineer
      • Oct 2019 - Oct 2021

    • Chemical Manufacturing
    • 700 & Above Employee
    • Intern
      • Jul 2016 - Oct 2016

      Internship at the Pharmaceuticals Division, Regulatory Affairs Department. - Instructions for the medical use of hormonal contraceptives: preparation of draft amendments, preparation of justification documents, preparation of dossiers, creation of statements on the regulator's website; - Regulatory documentation for an antibacterial drug of the fluoroquinolone group, a calcium channel blocker with a predominant effect on cerebral vessels and an antibiotic of the oxazolidinone group: preparation of draft amendments, preparation of dossiers for submission, creation of applications on the regulator's website; - Participation in a project to compile normative documentation for a number of drugs for women's and men's health, as well as for general therapy drugs. Show less

Education

  • MIREA (Russian Technological University)
    Doctor of Philosophy - PhD, Pharmaceutical Sciences
    2021 -
  • MIREA (Russian Technological University)
    Postgraduate Degree, Chemical Technology/Technician
    2017 - 2021
  • MIREA (Russian Technological University)
    Master's degree, Biotechnology
    2015 - 2017
  • MIREA (Russian Technological University)
    Bachelor's degree, Biotechnology
    2011 - 2015

Community

You need to have a working account to view this content. Click here to join now